1. Home
  2. CART vs NUVL Comparison

CART vs NUVL Comparison

Compare CART & NUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Maplebear Inc.

CART

Maplebear Inc.

HOLD

Current Price

$47.87

Market Cap

9.6B

Sector

N/A

ML Signal

HOLD

Logo Nuvalent Inc.

NUVL

Nuvalent Inc.

HOLD

Current Price

$123.81

Market Cap

9.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CART
NUVL
Founded
2012
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.8B
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
CART
NUVL
Price
$47.87
$123.81
Analyst Decision
Buy
Strong Buy
Analyst Count
21
16
Target Price
$52.24
$134.75
AVG Volume (30 Days)
4.2M
4.3M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
1.27
N/A
EPS
0.57
N/A
Revenue
$3,742,000,000.00
N/A
Revenue This Year
$13.44
N/A
Revenue Next Year
$9.71
$1,239.49
P/E Ratio
$83.07
N/A
Revenue Growth
10.78
N/A
52 Week Low
$32.73
$71.14
52 Week High
$53.50
$123.80

Technical Indicators

Market Signals
Indicator
CART
NUVL
Relative Strength Index (RSI) 63.38 66.91
Support Level $38.62 $98.56
Resistance Level $49.21 N/A
Average True Range (ATR) 1.85 0.18
MACD 0.14 -0.46
Stochastic Oscillator 78.46 99.07

Price Performance

Historical Comparison
CART
NUVL

About CART Maplebear Inc.

Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, allows couriers to earn income, and helps grocers to scale their business through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 1,800 retail partners, Instacart delivers to about 98% of households in the United States and Canada.

About NUVL Nuvalent Inc.

Nuvalent Inc is a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer. All of its operations are in the United States. The company is engaged in developing small molecules that are designed to overcome the limitations of existing therapies for clinically validated kinase targets. The product candidates of the company include NVL-520, which is being developed for patients with ROS1-positive non-small cell lung cancer (NSCLC), NVL-655, which is being developed for patients with anaplastic lymphoma kinase (ALK)-positive NSCLC, NVL-330, is a brain-penetrant human epidermal growth factor receptor 2 (HER2)-selective inhibitor designed to address the combined medical need of treating tumors driven by HER2ex20.

Share on Social Networks: